SC amivantamab, in combination with LAZCLUZE, is recommended for adult patients with advanced NSCLC with epidermal growth ...

Helsinki-based Aplagon has raised EUR 7 million to advance its APAC therapeutic for thrombo-inflammatory diseases into phase ...

Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol ...

The US Food and Drug Administration (FDA) has approved Eisai and Biogen’s Supplemental Biologics License Application for once ...

Distributing reliable information about medicines is challenging for the pharma industry and the healthcare professionals ...

Alliance Healthcare UK has announced that Paula Sutherland has been appointed to the position of Sales Director. Paula will ...

Yet only 5% have an approved therapy, and none offers a cure, leaving a significant unmet medical need. Due to the limited ...

The pharmaceutical industry stands at a crucial juncture, poised to be reshaped by transformative technology advancement.

Commit Biologics has announced the appointment of Janine Schuurman to its Board of Directors. Janine is a widely recognised ...

Imperative for AI-powered productivity enhancement ...

The revelation by the record-breaking Olympic cyclist Sir Chris Hoy that he has an untreatable form of prostate cancer, was a ...

The need to get digital products to market quickly is a common problem among teams in the pharma industry.